Effects of a parathyroidectomy on the immune system and nutritional condition in chronic dialysis patients with secondary hyperparathyroidism

American Journal of Surgery

Volumn 178, Issue 4, 1999, Pages 332-336

  Yasunaga, Chikao ^a   Nakamoto, Masahiko ^a   Matsuo, Kenzo ^a   Nishihara, Gakusen ^a   Yoshida, Tetsuhiko ^a   Goya, Tadanobu ^a  

^a Saiseikai Yahata Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; SERUM ALBUMIN;

ADULT; AGED; ARTICLE; CELLULAR IMMUNITY; DIALYSIS; FEMALE; HEMATOCRIT; HUMAN; IMMUNE SYSTEM; IMMUNOGLOBULIN BLOOD LEVEL; MALE; NUTRITIONAL STATUS; PARATHYROIDECTOMY; PRIORITY JOURNAL; SECONDARY HYPERPARATHYROIDISM;

ADULT; ANTIBODY FORMATION; FEMALE; HUMANS; HYPERPARATHYROIDISM, SECONDARY; IMMUNITY, CELLULAR; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; NUTRITIONAL STATUS; PARATHYROIDECTOMY; PROSPECTIVE STUDIES; RENAL DIALYSIS; TIME FACTORS;

EID: 0032729274     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9610(99)00194-4     Document Type: Article

References (35)

1. Wilson W.E.C., Kirkpatrick C.H., Talmage D.W. Suppression of immunologic responsiveness in uremia. Ann Intern Med. 62:1965;1-14.
2. Goldblum S.E., Reed W.P. Host defenses and immunologic alterations associated with chronic hemodialysis. Ann Intern Med. 93:1980;597-613.
3. Descamps-Latscha B., Chatenoud L. Immunological disturbances in uremia. Massry S.G., Glassock J.R. Textbook of Nephrology. 3rd ed. 1995;1482-1488 Williams and Willkins, Baltimore.
4. Khan I.H., Catto G.R.D. Long-term complications of dialysis infection . Kidney Int. 43:1993;S143-S148.
5. Hoen B., Kessler M., Hesin D., Mayeux D. Risk factors for bacterial infections in chronic haemodialysis adult patients a multicentre prospective survey . Nephrol Dial Transplant. 10:1995;377-381.
6. Massry S.G., Alexiewicz J.M., Gaciong Z., Klinger M. Secondary hyperparathyroidism and the immune system in chronic renal failure. Semin Nephrol. 11:1991;186-201.
7. Klinger M., Alexiewicz J.M., Linker-Israeli M., et al. Effect of parathyroid hormone on human T cell activation. Kidney Int. 37:1990;1543-1551.
8. Shasha S.M., Kristal B., Barzilai M., et al. In vitro effect of PTH on normal T cell functions. Nephron. 50:1988;212-216.
9. Jiang Y., Yoshida A., Ishioka C., et al. Parathyroid hormone inhibits immunoglobulin production without affecting cell growth in human B cells. Clin Immunol Immunopathol. 65:1992;286-293.
10. Lewin E., Ladefoged J., Brandi L., Olgaard K. Parathyroid hormone dependent T cell proliferation in uremic rats. Kidney Int. 44:1993;379-384.
11. Gaciong Z., Alexiewicz J.M., Massry S.G. Impaired in vivo antibody production in CRF rats role of secondary hyperparathyroidism . Kidney Int. 40:1991;862-867.
12. Giacchino F., Alloatti S., Quarello F., et al. The immunological state in chronic renal insufficiency. Int J Artif Organs. 5:1982;237-242.
13. Raziuddin S., Al-Janadi M.A., Al-Wabel A.A. Soluble interleukin 2 receptor levels in serum and its relationship to T cell abnormality and clinical manifestations of the disease in patients with systemic lupus erythematosus. J Rheumatol. 18:1991;831-836.
14. Caruana R.J., Leffell M.S., Lobel S.A., et al. Chronic T-lymphocyte activation in chronic renal failure a study of hemodialysis, CAPD and pre-dialysis patients . Int J Artif Organs. 15:1992;93-98.
15. Descamps-Latscha B., Herbelin A., Nguyen A.T., et al. Balance between Il-1β, TNF-α, and their specific inhibitors in chronic renal failure and maintenance dialysis. J Immunol. 154:1995;882-892.
16. Hory B., Racadot E., Saint-Hillier Y., et al. Soluble interleukin-2 receptors in chronic renal failure. Am J Nephrol. 11:1991;276-280.
17. Raska K., Raskova J., Shea S.M., et al. T cell subsets and cellular immunity in end-stage renal disease. Am J Med. 75:1983;734-740.
18. Mattern W.D., Hak L.J., Lamanna R.W., et al. Malnutrition, altered immune function, and the risk of infection in maintenance hemodialysis. Am J Kidney Dis. 1:1982;206-218.
19. Rothmund M., Wagner P.K. Total parathyroidectomy and autotransplantation of parathyroid tissue for renal hyperparathyroidism. Ann Surg. 208:1983;7-16.
20. Takagi H., Tominaga Y., Tanaka Y., et al. Total parathyroidectomy with forearm autograft for secondary hyperparathyroidism in chronic renal failure. Ann Surg. 208:1988;639-644.
21. Bland K.I., Tidwell S., von Fraunhofer J.A., et al. Intraoperative localization of parathyroid glands using methylothionine chloride tetramethy lthionine chloride in secondary hyperparathyroidism. Surg Gynecol Obstet. 160:1985;42-47.
22. Hruska K.A., Kopelman R., Rutherford W.E., et al. Metabolism of immunoreactive parathyroid hormone in the dog. J Clin Invest. 56:1975;39-48.
23. Togashi K., Takahashi N., Ando K., et al. Comparison of different parathyroid hormone radioimmunoassays in uremic patients with secondary hyperparathyroidism. Int J Artif Organs. 3:1990;77-82.
24. Stenver D.I., Gotfredsen A., Hilsted Jannik, Nielsen B. Body composition in hemodialysis patients measured by dual-energy X-ray absorptiometry. Am J Nephrol. 15:1995;105-110.
25. Glassock R.J., Massry S.G. Immunological disturbances in uremia. Massry S.G., Glassock J.R. Textbook of Nephrology. 2nd ed. 1989;1331-1332 Williams and Willkins, Baltimore.
26. Alexiewicz J.M., Klinger M., Pitts T.O., et al. Parathyroid hormone inhibits B cell proliferation implications in chronic renal failure . J Am Soc Nephrol. 1:1990;236-244.
27. Gaciong Z., Alexiewicz J.M., Linker-Islaeli M., et al. Inhibition of immunoglobulin production by parathyroid hormone. Implications in chronic renal failure. Kidney Int. 40:1991;96-106.
28. Antonucci F., Vezzadini P., Cecchettin M., et al. Gastric acid secretion, calcitonin and secondary hyperparathyroidism in uremic patients undergoing regular dialysis therapy (RDT). Int J Artif Organs. 1:1978;260-265.
29. Reisman T.N., Perez G.O., Rogers A.I. Gastric secretory function in patients with chronic renal failure undergoing maintenance hemodialysis. Am J Dig Dis. 21:1976;1044-1048.
30. Shaw J.H., Croxon M., Holdaway I., et al. Glucose, fat and protein kinetics in patients with primary and secondary hyperparathyroidism. Surgery. 103:1988;526-532.
31. Angelini D., Carlini A., Mazzotta L., et al. Immunologic disturbances and levels of parathyroid hormone in uremic patients in replacement therapy. Clin Nephrol. 42:1994;246-250.
32. Alexiewicz J.M., Gaciong Z., Klinger M., et al. Evidence of impaired T cell function in hemodialysis patients potential role for secondary hyperparathyroidism . Am J Nephrol. 10:1990;495-501.
33. Quesada J.M., Serrano I., Borrego F., et al. Calcitriol effect on natural killer cells from hemodialyzed and normal subjects. Calcif Tissue Int. 56:1995;113-117.
34. Lind L., Wengle B., Sorensen O.H., Ljunghall S. Delayed hypersensitivity in primary and secondary hyperparathyroidism. Treatment with active vitamin D. Exp Clin Endocrinol. 95:1990;271-274.
35. Cohen G., Haag-Weber M., Horl W.H. Immune dysfunction in uremia. Kidney Int. 52:1997;S79-S82.